Spectral Medical Inc T.EDT

Baxter Redaction and Interest

[Accountprince]

The only customer is Baxter.  They have exclusivity for distribution of PMX and the EAA.  They have already started the marketing program so that upon approval from the FDA they can hit the ground running.  The only reason for Spectral to market more broadly is to gain wider interest in Spectral stock with a view to the stock price moving towards it's true value.  Something the BOD and management have not done very well or at all from my observations.

Baxter is the key.  We have no idea what the deal with them is.  If it was just a series of milestone payments the need for redaction - if there ever was a need - has long passed.  It just isn't a valid reason for witholding the information for almost four years now.  Therefore, there must be something else in the deal that is redactionworthy.  And since we're exceeding expectations on 72 enrolled on the way to 90 enrolled that milestone is effectively achieved - only timing to be determined and that will be by the end of 2023.  I wouldn't be surprised to see Baxter - or KidneyCo - take over the trial at that stage through a buyout of Spectral.  I think the time is drawing near and Spectral has no choice but to get to 90 enrolled by the end of this year.  At which time I'm guessing we may see what is under that redaction ink after four years.  And hopefully the payday we've all been waiting for.

[mercedesman]

Right on as usual AP Why market Spectral when there is already someone waiting to take Ad-Vantive of the situation ? Wish I was a fly on the wall to know the redacted and unwritten bits  90 could be interesting.  Might take a few months into 2024 to sort out.  Any marketing might be directed at would be patients/relatives in order  to convince them to sign up to

[Bagelboy74]

Great to see the price climb so high and the huge volume. Should have never doubted you MM

[mercedesman]

You're welcome.!! A 66% rise in price ( .24 to .40) in less than 3 months is both exciting... and rewarding. The FUD worker(s) is (are) having some difficulty explaining this away.  It'll become increasingly difficult for him (them) to heap criticism on others, as the pace of enrolment accelerates this fall ( more staff availability, more sites, etc.)  I think we are in

[Spamme54321]

MercedesLadyBoy yes EDT has gone from .24 to .4 but what is the total dollar value in that move. I bet less than $1 million dollar worth of EDT shares were traded. That is a nothing burger. We need some  multi-million share volume days for anything big to happen. So you extraploate a .24 to .40 move to $10 move. Pumper keeps on pumping. Looks like EDT momentum fading until the next news

[Revten]

Wow! Lots of Bashing Today From The True Shill Boys!   It's going to be fun near year's end when you guys will be crying the blues because you missed an Opportunity Of A Lifetime! You actually think that those /we who are holding the majority of the outstanding shares are going to listen to your nonsense?? Who know full well that this is only a matter of When and not If?? Who stand

[Spamme54321]

Miss out on what? $50k might be alot of money to you since you work behind Wendys. But its really not relevant. Too bad you can't handle the truth. Haven't you been holding this bag for like a decade?

[hmmmmmmmm]

The shill performance art is hilarious. Here's Rev almost 4 years ago shouting about unicorns and cotton candy. "I plan on Selling a Few Shares at around $20.70 a Share... and will probably regret that I SOLD at that price! ....but that's why it will only be a Few Shares.... for now I am still Buying at these levels! Huge Bargain!! Thanks Annonomous! "   "Cheers

[ChesterLives]

It makes sense to me that Baxter may take out Spectral at 90 patients. If what we are told is true, they are geared up to hit the road with PMX very shortly. Makes me think that they may want to control the stretch run... assuming one is required. I also have a feeling that the little discussed Eden study may play a bigger role than anticipated in hitting this 150 number.

[mercedesman]

Thx for your thoughts Chester I believe that Eden has many functions including: -recruitment ( enrolment acceleration )  -label expansion ( future revenues)  -dose determination  (future revenues)  - etc.  I also think that Baxter is exerting more influence on timing and SP than we know  MM